期刊文献+

P53在乳腺癌组织中的表达及其与预后的关系 被引量:1

Expression and Prognosis Predicting Value Of P53 in Breast Cancer
暂未订购
导出
摘要 目的探讨P53在乳腺癌中的表达及其与预后的关系。方法收集2007~2010年乳腺癌仿根治术标本81例,采用免疫组化法检测乳腺癌中P53、ER、PR和C-erbB-2的表达,并分析P53与预后因子ER、PR和C-erbB-2及淋巴结转移的关系。结果 P53阳性率为84.0%,其表达与预后正性因子ER、PR呈负相关,而与预后负性因子C-erbB-2、腋窝淋巴结转移呈正相关,其差异有统计学意义(P<0.05)。结论 P53高表达是乳腺癌预后的负性相关因子之一。 Objective To explore the expression and prognosis predicting value of P53 in breast cancer.Methods The expressions of P53,ER,PR and C-erbB-2 were detected by IHC method in 81 cases of breast cancer since 2007 to 2010.The correlation between P53 and ER,PR,C-erbB-2 and 1ymphnode metastasis were analyzed.Results The over expression of P53 existed in 68 cases of 81 breast cancer(84.0%).It was negatively related with prognosis-positive predicting factors such as ER,PR,while positively related with prognosis-negative predicting factors such as C-erbB-2 and lymphnode metastasis.Conclusion In breast cancer,the over expression of P53 is one of the negative prognosis predicting factors.
出处 《中国实用医药》 2011年第9期31-32,共2页 China Practical Medicine
关键词 乳腺癌 P53 ER PR C-ERBB-2 免疫组化 Breast cancer P53 ER PR C-erbB-2 IHC
  • 相关文献

参考文献7

  • 1徐兵河.乳腺癌.北京:北京大学出版社,2006:7.
  • 2Schintt SJ.Breast cancer in 21 st century:neu opportunities and neu challenges.Mod Pathol,2001,14(3):133-146.
  • 3Petit T,Borel C,Ghnassia JP,et al.Chemotherapy response of breast cancer depends on HER2 status and anthracycline dose intensity in the neoadjuvant setting.Clin Cancer Res,2001,7(6):1577-1581.
  • 4Slamon DJ,Leyland Jones B,Shak S,et al.Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2.Engl J Med,2001,344(11):783-792.
  • 5Matsubara T.K-ras point mutations in cancerous and noncancerous biliary epithelium in patient with pancreaticobi1iary maljunction.Cancer,1996,77:1752.
  • 6Davidoff A M,Hernodom J E,Glover N S,et al.Relation between P53 overepression and established prognostic factors in breast cancer.Surgery,1991,110:259.
  • 7黄玉钿,郑曦,黄双月,吴钦穗,成辉.乳腺癌P53、CA153的表达及意义[J].中国实验诊断学,2005,9(2):221-224. 被引量:15

二级参考文献12

  • 1万文徽,李吉友.肿瘤标志的临床应用[J].中华医学检验杂志,1997,20(1):49-51. 被引量:180
  • 2Tahara E. Genetic alterations in human gastrointestinal cancers. The application to molecular diagnosis[J]. Cancer, 1995,75:1410.
  • 3许良中.预后的生物学标记[A].见:许良中主编.乳腺病理学[M].上海:上海医科大学出版社,1999.359.
  • 4Page DL, Ellis IO, Elston CW. Histologic grading of breast cancer. Let's do it(editorial)[J]. Am J Clin Pathol, 1995,103:123.
  • 5Matsubara T. K-ras point mutations in cancerous and noncancerous biliary epithelium in patient with pancreaticobiliary maljunction [J]. Cancer,1996,77:1752.
  • 6Levine AL, Momand J, Finlay CA. The p53 tumour suppressor gene[J].Nature, 1991,351(6326) :453.
  • 7Davidoff AM, Herndom JE, Glover NS, et al. Relation between P53overexpression and established prognostic factors in breast cancer [J].Surgery, 1991,110:259.
  • 8Zhao R, Gish K, Murphy M, et al. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays[J]. Genes Dec, 2000,14:981.
  • 9Haglund C, Lundin J, Kuusela D, et al. Ca242 a new tumor marker for pancreatic cancer[J]. BrJ Cancer, 1994,70:487.
  • 10Essmann-Seboth D, Fuchs I, Jakesz R, et al. CA15-3 in the postoperative follow-up of breast cancer patients. In:Klapdor R, eds. Current tumor diagnosis: application, clinical relevance, research, trends[M].New York: W Zuckschwerdt Verlag, 1994.158- 159.

共引文献15

同被引文献4

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部